Advanced search
Publication Cover
Emerging Microbes & Infections Volume 12, 2023 - Issue 2
Submit an article Journal homepage
2,009
Views
3
CrossRef citations to date
0
Altmetric
Coronaviruses

A follow-up study on the recovery and reinfection of Omicron COVID-19 patients in Shanghai, China

Mengna Lina Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;c Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Kangli Caob Clinical Center for Bio-Therapy, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Feixiang Xua Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Xueling Wud Department of Respiratory Medicine, Renji hospital, Shanghai jiaotong University, School of medicine, 160 Pujian Road, Shanghai, ChinaView further author information
,
Yao Shene Department of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Su Lua Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Zhongshu Kuanga Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Hailin Dinga Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Shuyun Yuana Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Mian Shaoa Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Guorong Gua Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Lingyu Xinga Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Tianwen Gua Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Shaodie Chena Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Jian Suna Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Jiamin Zhua Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Xiaoyan Zhangb Clinical Center for Bio-Therapy, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Yilin Yanga Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Guoping Zhaof State Key Laboratory of Genetic Engineering, Fudan Microbiome Center, School of Life Sciences, Fudan University, Shanghai, People’s Republic of China;g Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Lihong Huangh Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Jianqing Xub Clinical Center for Bio-Therapy, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;c Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Zhenju Songa Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China;c Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;i Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2261559 | Received 02 Jul 2023, Accepted 17 Sep 2023, Published online: 09 Oct 2023

References

  • Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. The Lancet Respiratory Medicine. 2021 Nov;9(11):1275–1287. doi:10.1016/S2213-2600(21)00383-0
  • Global Burden of Disease Long CC, Wulf Hanson S, Abbafati C, et al, et al. Estimated global proportions of individuals With persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. Jama. 2022 Oct 25;328(16):1604–1615. doi:10.1001/jama.2022.18931
  • Sigfrid L, Drake TM, Pauley E, et al. Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. The Lancet Regional Health Europe. 2021 Sep;8:100186. doi:10.1016/j.lanepe.2021.100186
  • Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022 Aug;28(8):1706–1714. doi:10.1038/s41591-022-01909-w
  • Jacobson KB, Rao M, Bonilla H, et al. Patients With uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: A cautionary tale during a global pandemic. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2021 Aug 2;73(3):e826–e829. doi:10.1093/cid/ciab103
  • Ballering AV, van Zon SKR, Hartman O, et al. Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet. 2022 Aug 6;400(10350):452–461. doi:10.1016/S0140-6736(22)01214-4
  • Antonelli M, Pujol JC, Spector TD, et al. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022 Jun 18;399(10343):2263–2264. doi:10.1016/S0140-6736(22)00941-2
  • Baskett WI, Qureshi AI, Shyu D, et al. COVID-Specific Long-term sequelae in comparison to common viral respiratory infections: An analysis of 17 487 infected adult patients. Open Forum Infect Dis. 2023 Jan;10(1). ofac683. doi:10.1093/ofid/ofac683
  • Jiang WQ, Li XS, Zhong WH, et al. Comparison of clinical characteristics in patients with coronavirus disease and influenza A in Guangzhou, China. World J Emerg Med. 2021;12(4):287–292. doi:10.5847/wjem.j.1920-8642.2021.04.006
  • Pilz S, Theiler-Schwetz V, Trummer C, et al. SARS-CoV-2 reinfections: overview of efficacy and duration of natural and hybrid immunity. Environ Res. 2022 Jun;209:112911. doi:10.1016/j.envres.2022.112911
  • Fonseca MHG, de Souza TFG, de Carvalho Araujo FM, et al. Dynamics of antibody response to CoronaVac vaccine. J Med Virol. 2022 May;94(5):2139–2148. doi:10.1002/jmv.27604
  • Saure D, O'Ryan M, Torres JP, et al. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Lancet Infect Dis. 2022 Jan;22(1):56–63. doi:10.1016/S1473-3099(21)00479-5
  • Singh AK, Phatak SR, Singh R, et al. Humoral antibody kinetics with ChAdOx1-nCOV (covishield) and BBV-152 (covaxin) vaccine among Indian healthcare workers: A 6-month longitudinal cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study. Diabetes Metab Syndr. 2022 Feb;16(2):102424. doi:10.1016/j.dsx.2022.102424
  • Di D, Shi F, Yan F, et al. Hypergraph learning for identification of COVID-19 with CT imaging. Med Image Anal. 2021 Feb;68:101910. doi:10.1016/j.media.2020.101910
  • Maestre-Muniz MM, Arias A, Mata-Vazquez E, et al. Long-Term outcomes of patients with coronavirus disease 2019 at One year after hospital discharge. J Clin Med. 2021 Jun 30;10(13):2945. doi:10.3390/jcm10132945
  • Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. The Lancet Respiratory Medicine. 2022 Sep;10(9):863–876. doi:10.1016/S2213-2600(22)00126-6
  • Yang XY, Hou C, Shen Y, et al. Two-Year health outcomes in hospitalized COVID-19 survivors in China. Jama Netw Open. 2022 Sep 1;5(9):e2231790. doi:10.1001/jamanetworkopen.2022.31790
  • Huang CL, Huang LX, Wang YM, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (publication with expression of concern. See vol. 401, pg. 90, 2023). Lancet. 2021 Jan 16;397(10270):220–232. doi:10.1016/S0140-6736(20)32656-8
  • Bellan M, Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae Among patients With COVID-19 four months after hospital discharge. Jama Netw Open. 2021 Jan 27;4(1). doi:10.1001/jamanetworkopen.2020.36142
  • Blomberg B, Mohn KGI, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021 Sep;27(9):1607. doi:10.1038/s41591-021-01433-3
  • Martimbianco ALC, Pacheco RL, Bagattini AM, et al. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021 Oct;75(10):e14357. doi:10.1111/ijcp.14357
  • Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022 Apr 12;13(1):1957. doi:10.1038/s41467-022-29521-z
  • Evans RA, Leavy OC, Richardson M, et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Resp Med. 2022 Aug;10(8):761–775. doi:10.1016/S2213-2600(22)00127-8
  • de Erausquin GA, Snyder H, Carrillo M, et al. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimers Dement. 2021 Jun;17(6):1056–1065. doi:10.1002/alz.12255
  • Song WJ, Hui CKM, Hull JH, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Resp Med. 2021 May;9(5):533–544. doi:10.1016/S2213-2600(21)00125-9
  • Yong SJ. Persistent brainstem dysfunction in long-COVID: A hypothesis. Acs Chem Neurosci. 2021 Feb 17;12(4):573–580. doi:10.1021/acschemneuro.0c00793
  • Ostergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021 Feb;9(3. doi:10.14814/phy2.14726
  • Guedj E, Campion JY, Dudouet P, et al. F-18-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol I. 2021 Aug;48(9):2823–2833. doi:10.1007/s00259-021-05215-4
  • Dhawan RT, Gopalan D, Howard L, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Resp Med. 2021 Jan;9(1):107–116. doi:10.1016/S2213-2600(20)30407-0
  • Clough E, Chean KT, Inigo J, et al. Mitochondrial dynamics in SARS-COV2 spike protein treated human microglia: implications for neuro-COVID. J Neuroimmune Pharm. 2021 Dec;16(4):770–784. doi:10.1007/s11481-021-10015-6
  • Stefano GB, Ptacek R, Ptackova H, et al. Selective neuronal mitochondrial targeting in SARS- CoV-2 infection affects cognitive processes to induce ‘brain fog’ and results in behavioral changes that favor viral survival. Med Sci Monitor. 2021 Jan 25;27:e930886. doi:10.12659/MSM.930886
  • Eythorsson E, Runolfsdottir HL, Ingvarsson RF, et al. Rate of SARS-CoV-2 reinfection during an omicron wave in Iceland. Jama Netw Open. 2022 Aug 3;5(8). doi:10.1001/jamanetworkopen.2022.25320
  • Keeling MJ. Patterns of reported infection and reinfection of SARS-CoV-2 in England. J Theor Biol. 2023 Jan 7;556. doi:10.1016/j.jtbi.2022.111299
  • Chemaitelly H, Ayoub HH, Tang PT, et al. Immune imprinting and protection against repeat reinfection with SARS-CoV-2. New Engl J Med. 2022 Nov 3;387(18):1716–1718. doi:10.1056/NEJMc2211055
  • Malato J, Ribeiro RM, Fernandes E, et al. Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months. Lancet Infect Dis. 2023 Feb;23(2):148–150. doi:10.1016/S1473-3099(22)00833-7
  • dos Santos LA, de Gois PG, Silva AMF, et al. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers. J Infection. 2021 Mar;82(3):399–406. doi:10.1016/j.jinf.2021.01.020
  • Abdelrahman MM, Abd-Elrahman NM, Bakheet TM. Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study. J Med Virol. 2021 Oct;93(10):5942–5946. doi:10.1002/jmv.27156
  • Bechmann N, Barthel A, Schedl A, et al. Sexual dimorphism in COVID-19: potential clinical and public health implications. Lancet Diabetes Endo. 2022 Mar;10(3):221–230. doi:10.1016/S2213-8587(21)00346-6
  • Hastie CE, Lowe DJ, McAuley A, et al. Outcomes among confirmed cases and a matched comparison group in the long-COVID in Scotland study (vol 13, 5663, 2022). Nat Commun. 2022 Oct 12;13(1):5663. doi:10.1038/s41467-022-33415-5.
  • Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022 Feb;23(2):194–202. doi:10.1038/s41590-021-01104-y
  • Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J Roy Soc Med. 2021 Sep;114(9):428–442. doi:10.1177/01410768211032850

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.